Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer
Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer
复制标题
DOI：
10.1002/ijc.31736
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Shangyong Zheng
中科院分区：
文献类型：
--
作者：
Yunchang Yuan;Guoxiang Qi;Hao Shen;Aizhen Guo;Fuao Cao;Yan Zhu;Chunjie Xiao;Wenjun Chang;Shangyong Zheng
In recent years, protein-protein interactions have become an attractive candidate for identifying biomarkers and drug targets.for various diseases. However, WD40 repeat (WDR) domain proteins, some of the most abundant mediators of protein.interactions, are largely unexplored. In our study, 57 of 361 known WDR proteins were identified as hub nodes, and a hub.(WDR54) with elevated mRNA in colorectal cancer (CRC) was selected for further study. Immunohistochemistry of specimens.from 945 patients confirmed the elevated expression of WDR54 in CRC, and we found that patients with WDR54-high tumors.typically had a shorter disease-specific survival (DSS) than those with WDR54-low tumors, especially for the subgroup without.well-differentiated tumors. Multivariate analysis showed that WDR54-high tumors were an independent risk factor for DSS,.with a hazard ratio of 2.981 (95% confidence interval, 1.425–6.234; p = 0.004). Knockdown of WDR54 significantly inhibited.the growth and aggressiveness of CRC cells and reduced tumor growth in a xenograft model. Each WDR54 isoform (a, b, and c).was found to reverse the inhibitory effect of WDR54 knockdown; however, only isoform c, which exhibited the highest.expression, was increased in CRC cells. Sensitization of WDR54 knockdown to an SHP2 inhibitor was consistently found in CRC.cells, and the underlying mechanism involved their common function in regulating AKT and ERK signaling. In conclusion, the.present study is the first to investigate the significance of WDR54 in cancer and to conclude that WDR54 serves as an.oncogene in CRC and may be a potential prognostic marker and therapeutic target.
